{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:22:23Z","timestamp":1762431743131,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,20]],"date-time":"2019-12-20T00:00:00Z","timestamp":1576800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"S\u00e3o Mamede do Coronado, Portugal"},{"name":"S\u00e3o Mamede do Coronado, Portugal"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Regulatory Toxicology and Pharmacology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.yrtph.2019.104557","type":"journal-article","created":{"date-parts":[[2019,12,19]],"date-time":"2019-12-19T12:36:14Z","timestamp":1576758974000},"page":"104557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Oral repeated-dose toxicity studies of BIA 10\u20132474 in CD-1 mice"],"prefix":"10.1016","volume":"111","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6316-3179","authenticated-orcid":false,"given":"A. Wallace","family":"Hayes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Pressman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jerry F.","family":"Hardisty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen B.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yrtph.2019.104557_bib1","series-title":"Saint-Denis","article-title":"Report by the temporary specialist scientific committee (TSSC): FAAH (fatty acid amide hydrolase),\u201d on the causes of the accident during a phase 1 clinical trial in rennes in january 2016","author":"CSST","year":"2016"},{"key":"10.1016\/j.yrtph.2019.104557_bib2","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1080\/01621459.1955.10501294","article-title":"A multiple comparison procedure for comparing several treatments with a control","volume":"50","author":"Dunnett","year":"1955","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.yrtph.2019.104557_bib3","series-title":"Proceedings of the British Pharmacological Society","article-title":"Preliminary safety evaluation in study BIA-10-2474-101","author":"Gama","year":"2016"},{"key":"10.1016\/j.yrtph.2019.104557_bib4","article-title":"Oral repeated-dose toxicity studies of BIA 10-2474 in beagle dogs","author":"Hardisty","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"year":"2019","series-title":"Developmental and Reproductive Toxicity Studies of BIA 10-2474. Regulatory Toxicology & Pharmacology","author":"Harris","key":"10.1016\/j.yrtph.2019.104557_bib5"},{"key":"10.1016\/j.yrtph.2019.104557_bib6","article-title":"Oral repeated-dose toxicity studies of BIA 10-2474 in Wistar rat","author":"Hayes","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104557_bib7","article-title":"The absence of genotoxicity of a novel fatty acid amide hydrolase inhibitor, BIA 10-2474","author":"Hayes","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104557_bib8","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1056\/NEJMoa1604221","article-title":"Acute neurologic disorder from an inhibitor of fatty acid amide hydrolase","volume":"375","author":"Kerbrat","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.yrtph.2019.104557_bib9","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1002\/cmdc.201800393","article-title":"Discovery of a potent, long-acting, and CNS-active inhibitor (BIA 10-2474) of fatty acid amide hydrolase","volume":"13","author":"Kiss","year":"2018","journal-title":"ChemMedChem"},{"year":"1981","series-title":"Simultaneous Statistical Inferences","author":"Miller","key":"10.1016\/j.yrtph.2019.104557_bib10"},{"key":"10.1016\/j.yrtph.2019.104557_bib11","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1002\/cpt.118","article-title":"Cannabinoid abuse and addiction: clinical and preclinical findings","volume":"97","author":"Panlilio","year":"2015","journal-title":"Clin. Pharmacol. Ther."},{"key":"10.1016\/j.yrtph.2019.104557_bib12","first-page":"51","article-title":"FAAH and MAGL inhibitors: therapeutic opportunities from regulating endocannabinoid levels","volume":"11","author":"Petrosino","year":"2010","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"10.1016\/j.yrtph.2019.104557_bib13","series-title":"Proceedings of the British Pharmacological Society","article-title":"Tolerability, pharmacokinetic and pharmacodynamic profile of BIA 10-2474 in healthy volunteers following multiple ascending doses","author":"Rocha","year":"2016"},{"key":"10.1016\/j.yrtph.2019.104557_bib14","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/sj.bjp.0707460","article-title":"The orphan receptor GPR55 is a novel cannabinoid receptor","volume":"152","author":"Ryberg","year":"2007","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.yrtph.2019.104557_bib15","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.lfs.2018.04.054","article-title":"Enhanced endocannabinoid tone as a potential target of pharmacotherapy","volume":"204","author":"Toczek","year":"2018","journal-title":"Life Sci."},{"key":"10.1016\/j.yrtph.2019.104557_bib16","article-title":"Oral repeated-dose toxicity studies of BIA 10-2474 in Cynomolgus monkeys","author":"Weber","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."}],"container-title":["Regulatory Toxicology and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019303216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0273230019303216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T12:29:14Z","timestamp":1759494554000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0273230019303216"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":16,"alternative-id":["S0273230019303216"],"URL":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.104557","relation":{},"ISSN":["0273-2300"],"issn-type":[{"type":"print","value":"0273-2300"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral repeated-dose toxicity studies of BIA 10\u20132474 in CD-1 mice","name":"articletitle","label":"Article Title"},{"value":"Regulatory Toxicology and Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yrtph.2019.104557","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"104557"}}